Plain-English research reference
What do peptides do?
Peptides are short chains of amino acids that can act as signals in biological systems. Different peptides interact with very different pathways, so there is no single “peptide effect.” Open any entry below to understand what it is, why researchers study it and how strong the evidence currently is.
Detailed guides
Main catalogue peptides
RetatrutideOpen guide
An investigational metabolic peptide designed to act on three hormone-receptor pathways involved in appetite, glucose regulation and energy balance.
What is it?
Retatrutide is a triple receptor agonist being developed to activate GLP-1, GIP and glucagon receptors. GLP-1 and GIP are incretin pathways involved in appetite and insulin signalling, while glucagon signalling also affects energy use and metabolism.
What is the research idea?
Researchers are studying whether activating all three pathways together can influence satiety, food intake, glucose control, energy expenditure and body composition more broadly than a single-pathway compound.
What does the evidence say?
Phase 2 and reported phase 3 trials investigate weight and metabolic outcomes. Retatrutide remains investigational and is not an approved UK medicine; longer-term safety still matters.
- Appetite and satiety signalling
- Glucose and insulin response
- Energy balance
- Body-weight research
TirzepatideOpen guide
A dual GIP and GLP-1 receptor agonist used in authorised prescription medicines for type 2 diabetes and weight management.
What is it?
Tirzepatide activates the GIP and GLP-1 incretin receptors. These pathways are involved in insulin release, glucose regulation, appetite signalling, gastric emptying and the feeling of fullness after eating.
What is the research idea?
Trials investigate the combined GIP and GLP-1 pathway effects on appetite, body weight, blood-glucose markers and wider cardiometabolic outcomes. Findings describe the products and populations studied.
What does the evidence say?
Tirzepatide has established clinical evidence and authorised medical uses, but licensed treatment must use an approved prescription product under appropriate healthcare supervision. Unlicensed research material is not equivalent to an authorised medicine.
- GIP and GLP-1 signalling
- Appetite regulation
- Glucose control
- Metabolic research
IGF-1 LR3Also known as Long R3 IGF-1Open guide
A laboratory-modified analogue of insulin-like growth factor 1 used to investigate growth-factor signalling.
What is it?
IGF-1 LR3 is an altered form of IGF-1 designed to remain active for longer in experimental systems and bind less readily to some IGF-binding proteins. It is distinct from naturally circulating human IGF-1.
What is the research idea?
Laboratory work uses it to explore IGF-1 receptor signalling, protein synthesis, cell growth, glucose handling and tissue-development pathways.
What does the evidence say?
It is a research reagent rather than an approved medicine. Commercial material, biological activity and purity can vary, and claims about bodybuilding or recovery should not be treated as proven clinical outcomes.
- IGF-1 receptor signalling
- Cell growth
- Protein synthesis
- Metabolic pathways
MOTS-COpen guide
A mitochondria-derived peptide studied as a signal connecting cellular stress, energy use and metabolic adaptation.
What is it?
MOTS-C is encoded within mitochondrial DNA. Under experimental stress it can interact with cellular and nuclear signalling networks, including pathways associated with AMPK and energy homeostasis.
What is the research idea?
Researchers investigate how MOTS-C relates to insulin sensitivity, metabolic flexibility, exercise response, inflammation, cellular stress and biological ageing.
What does the evidence say?
Most intervention evidence remains preclinical. Human studies have explored associations and biological responses, but marketed research MOTS-C is not an approved treatment for performance, ageing or metabolic disease.
- Mitochondrial signalling
- Energy metabolism
- Stress adaptation
- Exercise-response research
BPC-157 + TB-500Also known as WolverineOpen guide
A catalogue combination of two separate experimental materials commonly discussed in tissue-repair research.
What is it?
BPC-157 is a synthetic 15-amino-acid peptide investigated mainly in preclinical tissue and gastrointestinal models. TB-500 is a commercial research name generally associated with thymosin-beta-4-related material; its exact sequence must be confirmed analytically.
What is the research idea?
The two are discussed around cell migration, blood-vessel formation, inflammation, collagen organisation and repair signalling in muscle, tendon, ligament, skin and other tissues.
What does the evidence say?
The evidence bases for the two materials are not interchangeable. BPC-157 lacks robust controlled human trials, while thymosin beta-4 has separate research history. The combined 'Wolverine' format is not an approved clinical formulation.
- Preclinical tissue repair
- Cell migration
- Inflammatory signalling
- Wound-repair pathways
KPVOpen guide
A three-amino-acid fragment of alpha-melanocyte-stimulating hormone investigated for anti-inflammatory signalling.
What is it?
KPV is the short lysine-proline-valine sequence at the end of alpha-MSH. It does not appear to depend on the same classical melanocortin-receptor activity as the full hormone.
What is the research idea?
Experimental studies examine inflammatory-cell migration, cytokine signalling, epithelial barriers, skin models and gastrointestinal inflammation.
What does the evidence say?
The strongest evidence is laboratory and animal research. KPV is not an approved treatment, and findings from experimental models cannot establish effects in people.
- Inflammatory signalling
- Barrier research
- Skin models
- Gastrointestinal models
GHK-CuAlso known as Copper tripeptide-1Open guide
A naturally occurring copper-binding tripeptide researched in skin, extracellular-matrix and wound-repair biology.
What is it?
GHK is a three-amino-acid peptide that can bind copper ions. GHK-Cu is studied as a signalling complex involved in fibroblast activity, collagen and elastin-related processes, antioxidant responses and tissue remodelling.
What is the research idea?
Research explores skin appearance, wound models, collagen synthesis, extracellular-matrix organisation, inflammation and hair-follicle biology.
What does the evidence say?
There is substantial laboratory and cosmetic interest, but clinical evidence varies by formulation and use. Evidence for topical formulations cannot automatically be transferred to injectable or uncharacterised research material.
- Collagen and elastin research
- Skin remodelling
- Wound models
- Hair-follicle research
EpitalonAlso known as EpithalonOpen guide
A synthetic tetrapeptide promoted in ageing research, but supported by a limited and difficult-to-generalise evidence base.
What is it?
Epitalon is the short sequence Ala-Glu-Asp-Gly. Research discussions commonly focus on cellular ageing, oxidative stress, circadian biology and proposed effects involving telomerase or telomeres.
What is the research idea?
The central research question is whether this short peptide can influence age-related cellular processes or stress responses in experimental systems.
What does the evidence say?
Evidence is limited, much of it is preclinical or from small studies, and strong longevity claims are not established. Epitalon is not an approved anti-ageing medicine.
- Cellular ageing
- Oxidative stress
- Circadian research
- Telomere-related hypotheses
SemaxOpen guide
A synthetic ACTH-derived peptide investigated mainly in neurological, cognitive and stress-response research.
What is it?
Semax is a seven-amino-acid peptide derived from a fragment of adrenocorticotropic hormone but designed without the full hormone's corticosteroid activity.
What is the research idea?
Research has explored neuroprotective signalling, cognition, attention, stress responses, neurotrophic factors and recovery after neurological injury.
What does the evidence say?
Published research includes experimental and limited clinical work, much of it from a narrow geographic literature base. Claims about focus, mood or sleep should not be presented as established outcomes, and Semax is not an approved UK medicine.
- Neurological signalling
- Cognition research
- Stress response
- Neuroprotection hypotheses
SelankOpen guide
A synthetic tuftsin-derived peptide investigated in anxiety, stress and cognitive research.
What is it?
Selank is a seven-amino-acid analogue related to the naturally occurring immune peptide tuftsin. Laboratory studies have examined neurotransmitter, immune and peptide-degradation pathways.
What is the research idea?
Researchers have explored whether Selank influences anxiety-related behaviour, stress adaptation, memory and broader neuroimmune signalling.
What does the evidence say?
The evidence base is limited and does not support treating advertised mood or cognition benefits as guaranteed. Selank is not an approved UK medicine.
- Stress and anxiety research
- Cognitive models
- Neuroimmune signalling
- Peptide metabolism
Complete reference index
Every A–Z catalogue entry
These shorter entries explain the intended research idea behind every name in the wider catalogue. Open a letter, then select a product.
51 entries
5-Amino-1MQ
A small-molecule NNMT inhibitor used in preclinical metabolic research; it is not an approved medicine.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.A9 entries
ACE-031
An investigational soluble activin receptor designed to alter myostatin and related signalling in muscle research.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Acetic Acid Reconstitution Water
A dilute acidic laboratory diluent. Suitability depends on the material and protocol; it is not interchangeable with every reconstitution solution.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.ACTH 1-39
The full-length corticotropin peptide, studied for its role in stimulating adrenal corticosteroid production.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Adamax
A supplier catalogue name without a clearly established international non-proprietary identity; composition should be confirmed from a COA before research use.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Adipotide
An experimental peptide studied preclinically for effects on blood vessels associated with adipose tissue; it is not an approved treatment.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.AHK-Cu
A copper-binding tripeptide investigated in laboratory models involving skin, hair follicles and extracellular-matrix biology.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.AICAR
An adenosine analogue used in laboratory research to activate AMPK and investigate cellular energy regulation.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.AOD-9604
A modified fragment of human growth hormone studied for metabolic signalling; it is not an approved weight-management medicine in the UK.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.ARA-290 (Cibinetide)
An investigational erythropoietin-derived peptide studied for tissue-protective and anti-inflammatory signalling without red-cell stimulation.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.B3 entries
B7-33
A single-chain relaxin-family peptide investigated preclinically for fibrosis and tissue-remodelling pathways.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.BAC Water
Bacteriostatic water is sterile water containing a preservative. Laboratory use must follow the material specification and compatibility requirements.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.BPC-157
An experimental peptide widely used in preclinical tissue-repair research; reliable human clinical evidence is limited and it is not an approved medicine.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.C6 entries
Cagrilintide
A long-acting amylin analogue under clinical investigation for appetite and body-weight regulation.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Cagrilintide + Semaglutide
An investigational combination of an amylin analogue and a GLP-1 receptor agonist studied in metabolic and weight-management trials.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.CBL60
A supplier catalogue label whose exact chemical identity is not established by the name alone; verify the formulation and analytical documentation before research use.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.CJC-1295 No DAC
A catalogue name commonly used for modified GRF (1–29), a GHRH analogue without the drug-affinity-complex modification. Confirm its sequence; it is not simply the same molecule as CJC-1295 with DAC.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.CJC-1295 No DAC + Ipamorelin
A research blend combining a GHRH analogue with a ghrelin-receptor agonist; the blend is not an approved medicine.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.CJC-1295 With DAC
A longer-acting GHRH analogue incorporating a drug-affinity-complex modification, studied for growth-hormone signalling.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.D4 entries
Dermorphin
A potent opioid peptide originally identified in amphibian skin and used in receptor and analgesia research; it carries serious opioid-related risks.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Dihexa
An experimental small molecule derived from angiotensin-related research and studied preclinically for synaptic and neurotrophic pathways.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.DSIP
Delta sleep-inducing peptide is an experimental neuropeptide studied in sleep and stress research; its biological role remains uncertain.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Dulaglutide
A long-acting GLP-1 receptor agonist used as a prescription medicine for type 2 diabetes; catalogue information is for reference only.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.E1 entries
Epitalon
A synthetic tetrapeptide investigated in ageing and cell-regulation studies; robust clinical evidence and regulatory approval are lacking.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.F4 entries
Follistatin
A protein that binds activins and related growth factors, used in research on muscle, reproduction and tissue regulation.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.FOXO4
A transcription factor central to cell-cycle, stress-response and longevity research; the catalogue name alone does not define a particular peptide sequence.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.FOXO4-DRI
An experimental D-retro-inverso peptide studied preclinically for interactions involving FOXO4 and senescent cells.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.FST-344
A follistatin isoform investigated for its binding to activin and myostatin-family proteins in muscle and developmental research.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.G6 entries
GDF-8
Growth differentiation factor 8, also called myostatin, is a signalling protein studied for its role in limiting skeletal-muscle growth.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.GHK-Cu
A naturally occurring copper-binding tripeptide studied in laboratory models of wound repair, collagen biology and skin remodelling.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.GHRP-2
A synthetic ghrelin-receptor agonist studied for growth-hormone release and endocrine signalling.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.GHRP-2 Acetate
The acetate salt of GHRP-2, a synthetic ghrelin-receptor agonist used in experimental endocrine research.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Glutathione
A naturally occurring cellular antioxidant used in biochemical research on redox balance, detoxification and oxidative stress.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Gonadorelin Acetate
A synthetic form of gonadotropin-releasing hormone used to study pituitary LH and FSH release.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.H6 entries
HCG
Human chorionic gonadotropin is a hormone that acts at the LH receptor and is used clinically in specific prescribed settings and in reproductive research.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Hexarelin Acetate
A synthetic growth-hormone secretagogue and ghrelin-receptor agonist studied in endocrine research.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.HGH
Human growth hormone regulates growth and metabolism. It is a prescription-only biological medicine and should not be treated as a general research supplement.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.HGH Fragment 176-191
A C-terminal growth-hormone fragment investigated for metabolic signalling; it is not an approved medicine.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.HMG
Human menopausal gonadotropin contains gonadotropin activity and is used clinically under specialist supervision and in reproductive-endocrine research.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Humanin
A mitochondria-associated peptide investigated in preclinical studies of cellular stress, metabolism and neuroprotection.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.I3 entries
IGF-1 LR3
A long-acting laboratory analogue of insulin-like growth factor 1 used to study growth and metabolic signalling; it is not an approved medicine.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.IGF-DES
A shortened IGF-1 analogue used in experimental studies of IGF-receptor signalling and tissue growth.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Ipamorelin
A selective ghrelin-receptor agonist studied for growth-hormone release; it is not an approved medicine.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.K2 entries
Kisspeptin-10
A short active fragment of kisspeptin used to investigate hypothalamic control of reproductive hormone signalling.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.KPV
A tripeptide fragment of alpha-MSH investigated preclinically for inflammatory and barrier-related pathways.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.L6 entries
L-Carnitine
A naturally occurring compound involved in transporting fatty acids into mitochondria and widely studied in energy metabolism.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Lipo B
A supplier-defined lipotropic mixture; ingredients and concentrations vary, so the name alone is insufficient to establish composition.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Lipo C
A supplier-defined lipotropic mixture rather than a standardised drug name; verify every ingredient and concentration from the formulation record.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Lipo C with B12
A non-standardised lipotropic mixture that includes vitamin B12; exact composition varies between suppliers.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Liraglutide
A GLP-1 receptor agonist used as a prescription medicine for diabetes and weight management in approved products and indications.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.LL-37
A human antimicrobial peptide studied for innate immunity, inflammation and host-defence signalling.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.M7 entries
Mazdutide
A dual GLP-1 and glucagon receptor agonist studied in metabolic trials. Specific mazdutide medicines are authorised in China; that approval does not apply to a UK research-labelled catalogue item.
Innovent: Chinese regulatory and trial update ↗Research and reference information only. This is not a treatment recommendation or an approved-use claim.Melanotan I
An analogue of alpha-MSH related to afamelanotide and studied for melanocortin signalling and pigmentation.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Melatonin
A hormone involved in circadian timing and sleep regulation; legal and product classifications vary by country.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.MGF
Mechano growth factor is an IGF-1 splice-variant concept studied in muscle adaptation; commercial catalogue material may not match endogenous MGF.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.MK-677
Ibutamoren is an investigational small molecule, not a peptide, that activates the ghrelin receptor in growth-hormone and IGF-1 research.
Tocris: MK-0677 research identity ↗Research and reference information only. This is not a treatment recommendation or an approved-use claim.MOTS-C
A mitochondria-derived peptide investigated in preclinical research on cellular energy, stress responses and metabolic regulation.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.MT-2 · Melanotan II
An unapproved synthetic melanocortin analogue studied for pigmentation and related receptor effects; significant safety concerns have been reported.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.N1 entries
NAD+
Nicotinamide adenine dinucleotide is an essential cellular coenzyme studied in energy metabolism, redox reactions and ageing biology.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.O2 entries
Orexin B
A neuropeptide involved in wakefulness, arousal and energy-balance signalling, used in neuroscience research.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Oxytocin Acetate
The acetate salt of oxytocin, a peptide hormone involved in uterine, lactation and social-behaviour pathways.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.P5 entries
PE-22-28
An experimental spadin-derived peptide investigated preclinically for TREK-1 potassium-channel and neurobehavioural pathways.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.PEG-MGF
A pegylated catalogue form associated with mechano growth factor research; identity and biological comparability require analytical verification.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Pinealon
A short synthetic peptide investigated in limited experimental work involving neural and cellular ageing pathways.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.PNC-27
An experimental p53-derived peptide studied preclinically for interactions with cancer-cell membranes; it is not an approved cancer treatment.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.PT-141
Bremelanotide is a melanocortin-receptor agonist studied for sexual-function signalling; regulatory status and approved indications differ by country.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.R2 entries
Retatrutide
An investigational triple agonist targeting GLP-1, GIP and glucagon receptors in clinical studies of obesity and metabolic disease; it is not an approved medicine.
Lilly: current investigational programme ↗Research and reference information only. This is not a treatment recommendation or an approved-use claim.Retatrutide + Tirzepatide Blend
A non-standard experimental mixture of two incretin-pathway compounds. It is not an approved formulation and its composition requires independent verification.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.S8 entries
Selank
A synthetic peptide investigated in limited studies of anxiety, cognition and immune signalling; it is not an approved UK medicine.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Semaglutide
A GLP-1 receptor agonist used in authorised prescription medicines for diabetes and weight management; unlicensed material is not equivalent to an approved product.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Semax
A synthetic ACTH-derived peptide investigated in neurological and cognitive research; it is not an approved UK medicine.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Sermorelin
A growth-hormone-releasing-hormone analogue used in endocrine research and historically in some clinical settings.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.SLU-PP-332
An experimental small molecule described as an oestrogen-related-receptor agonist in preclinical metabolism and exercise-mimetic research.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.SNAP-8
A synthetic cosmetic peptide studied for effects on neurotransmitter-release machinery and the appearance of expression lines.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.SS-31
Elamipretide is a mitochondria-targeting peptide. The specific US medicine Forzinity received accelerated approval for Barth syndrome in patients weighing at least 30 kg; research-labelled SS-31 is not that authorised product.
FDA: specific Forzinity accelerated approval ↗Research and reference information only. This is not a treatment recommendation or an approved-use claim.Survodutide
An investigational dual glucagon and GLP-1 receptor agonist studied in obesity and metabolic liver disease.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.T7 entries
TB-500
A commercial research name generally associated with thymosin-beta-4-related material; exact sequence and composition should be analytically confirmed.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.TB-500 Fragment 17-23
A short thymosin-beta-4-derived fragment used in laboratory research; it is not an approved medicine.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Teriparatide
A parathyroid-hormone fragment used in authorised prescription medicines for osteoporosis and in bone-metabolism research.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Tesamorelin
A growth-hormone-releasing-factor analogue used in a specific approved indication in some countries and studied in metabolic research.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Thymalin
A thymic peptide preparation investigated in limited immune and ageing research; the catalogue name may represent a mixture rather than one defined molecule.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Thymosin Alpha-1
A thymic peptide investigated for immune-modulating effects and used clinically in some countries, but not universally authorised.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Tirzepatide
A dual GIP and GLP-1 receptor agonist used in authorised prescription medicines for diabetes and weight management.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.V3 entries
Vilon
A synthetic dipeptide investigated in limited studies of thymic, immune and gene-regulatory pathways.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.VIP · Vasoactive Intestinal Peptide
A naturally occurring neuropeptide involved in vascular tone, smooth muscle, secretion and immune signalling.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Vitamin B12
A group of cobalamin compounds essential for DNA synthesis, blood-cell formation and neurological function; the exact form should be specified.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.W2 entries
Wolverine · BPC-157 5 mg + TB-500 5 mg
A supplier-defined blend of two experimental peptide materials. It is not an approved formulation and each component requires independent verification.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.Wolverine · BPC-157 10 mg + TB-500 10 mg
A supplier-defined blend of two experimental peptide materials. It is not an approved formulation and each component requires independent verification.
Research and reference information only. This is not a treatment recommendation or an approved-use claim.